Combination treatment for newly diagnosed aplastic anemia
Treatments studied
Part of Blood & lymphatic clinical trials.
This trial tests a combination of drugs to help your bone marrow make more blood cells if you have aplastic anemia and cannot have a stem cell transplant or standard immune therapy. It might improve blood counts and reduce the need for transfusions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with severe or transfusion-dependent non-severe aplastic anemia.
- You do not have a matched stem cell donor or are not able to have a stem cell transplant.
- You cannot take anti-thymocyte globulin (ATG) because of age, other health problems, or your choice.
- Your liver and kidneys are working well enough (within normal limits).
- You are able to take care of yourself (ECOG score 0-2).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies using a donor's blood stem cells (from bone marrow or blood) for a transplant in people with severe aplastic anemia, a condition where the bone marrow stops making enough blood cells. The goal is to see if using a mix of both types of cells is better than just blood cells alone.
This trial tests whether a new drug called enarodustat, when combined with cyclosporine, can improve blood cell counts better than cyclosporine alone in people with transfusion-dependent non-severe aplastic anemia. If you qualify, you might need fewer transfusions and feel better overall.
This trial tests a new way to treat severe aplastic anemia by combining a stem cell transplant from a half-matched donor with special stem cells from umbilical cord blood. The goal is to help your body make healthy blood cells again.
This trial is testing an experimental medicine called Dibotatug (DR-01) for adults with aplastic anemia, a condition where the bone marrow stops making enough blood cells. It aims to see if the drug is safe and can help improve blood cell counts, especially for people whose disease has not improved with standard treatments.
This trial tests whether a new combination of medicines can help treat severe aplastic anemia (SAA) or a related type (TD-NSAA). It uses a drug that helps your body make more platelets, along with immunosuppressants, and may offer an alternative if a bone marrow transplant isn't possible.
This trial tests whether adding romiplostim, a drug that helps the body make platelets, to the usual treatment for severe aplastic anemia can improve blood cell counts. It is for people who have not yet started treatment for this condition.
Hear when a new Transfusion-dependent Non-severe Aplastic Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.